Vanicoside B is primarily studied for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in inhibiting pro-inflammatory cytokines, making it a candidate for research in autoimmune and chronic inflammatory conditions. Due to its natural origin and structural profile, it is also investigated for antioxidant effects, which may contribute to cellular protection against oxidative stress. Currently, its applications remain within preclinical research, focusing on drug discovery and development for inflammatory diseases. Further studies are needed to evaluate bioavailability, toxicity, and therapeutic efficacy in humans.